{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T06:43:47Z","timestamp":1792133027474,"version":"4.4.0"},"reference-count":120,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100001960","name":"American Society for Radiation Oncology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001960","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["practicalradonc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Practical Radiation Oncology"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.prro.2022.09.002","type":"journal-article","created":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T23:47:33Z","timestamp":1666396053000},"page":"41-65","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":93,"title":["Radiation Therapy for Endometrial Cancer: An American Society for Radiation Oncology Clinical Practice Guideline"],"prefix":"10.1016","volume":"13","author":[{"given":"Matthew M.","family":"Harkenrider","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadeem","family":"Abu-Rustum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Albuquerque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2703-0501","authenticated-orcid":false,"given":"Lisa","family":"Bradfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Bradley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Dolinar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne M.","family":"Doll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Elshaikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa A.","family":"Frick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola A.","family":"Gehrig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathy","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"Hathout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Klopp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Firas","family":"Mourtada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gita","family":"Suneja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexi A.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catheryn","family":"Yashar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth A.","family":"Erickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prro.2022.09.002_bib0001","series-title":"Clinical Practice Guidelines We Can Trust","article-title":"Committee on Standards for Developing Trustworthy Clinical Practice Guidelines","year":"2011"},{"key":"10.1016\/j.prro.2022.09.002_bib0002","series-title":"Finding What Works in Health Care: Standards for Systematic Reviews","article-title":"Committee on Standards for Systematic Reviews of Comparative Effectiveness Research","year":"2011"},{"key":"10.1016\/j.prro.2022.09.002_bib0003","unstructured":"National Cancer Institute. National Cancer Institute S, Epidemiology, and End Results Program cancer stat facts: Uterine cancer. Available at: https:\/\/seer.cancer.gov\/statfacts\/html\/corp.html. Accessed January 10, 2022."},{"key":"10.1016\/j.prro.2022.09.002_bib0004","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.prro.2014.01.003","article-title":"The role of postoperative radiation therapy for endometrial cancer: Executive summary of an American Society for Radiation Oncology evidence-based guideline","volume":"4","author":"Klopp","year":"2014","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.prro.2022.09.002_bib0005","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Kandoth","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.prro.2022.09.002_bib0009","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1111\/IGC.0b013e3181a6c9df","article-title":"Intravaginal brachytherapy in FIGO stage I low-risk endometrial cancer: A controlled randomized study","volume":"19","author":"Sorbe","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.prro.2022.09.002_bib0010","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1097\/IGC.0b013e3182a5e77d","article-title":"Omitting adjuvant radiotherapy in endometrial cancer increases the rate of locoregional recurrences but has no effect on long-term survival: The Danish Endometrial Cancer Study","volume":"23","author":"Ortoft","year":"2013","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.prro.2022.09.002_bib0011","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0140-6736(09)62163-2","article-title":"Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): An open-label, non-inferiority, randomised trial","volume":"375","author":"Nout","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.prro.2022.09.002_bib0012","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/s41416-018-0310-8","article-title":"Ten-year results of the PORTEC-2 trial for high-intermediate risk endometrial carcinoma: Improving patient selection for adjuvant therapy","volume":"119","author":"Wortman","year":"2018","journal-title":"Br J Cancer"},{"key":"10.1016\/j.prro.2022.09.002_bib0013","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1016\/j.ejca.2015.05.015","article-title":"Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer\u2014A pooled analysis of PORTEC 1 and 2 trials","volume":"51","author":"Bosse","year":"2015","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.prro.2022.09.002_bib0014","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ygyno.2003.11.048","article-title":"A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: A Gynecologic Oncology Group study","volume":"92","author":"Keys","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.prro.2022.09.002_bib0015","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/S0140-6736(00)02139-5","article-title":"Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: Multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma","volume":"355","author":"Creutzberg","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.prro.2022.09.002_bib0016","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0140-6736(08)61767-5","article-title":"Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): Pooled trial results, systematic review, and meta-analysis","volume":"373","author":"Group","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.prro.2022.09.002_bib0017","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1200\/JCO.2004.08.159","article-title":"Outcome of high-risk stage IC, grade 3, compared with stage I endometrial carcinoma patients: The Postoperative Radiation Therapy in Endometrial Carcinoma Trial","volume":"22","author":"Creutzberg","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2022.09.002_bib0018","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1093\/jnci\/djs374","article-title":"Adjuvant radiotherapy for stage I endometrial cancer: An updated Cochrane systematic review and meta-analysis","volume":"104","author":"Kong","year":"2012","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.prro.2022.09.002_bib0019","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/S1470-2045(19)30395-X","article-title":"Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): Patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial","volume":"20","author":"de Boer","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.prro.2022.09.002_bib0020","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1200\/JCO.18.01575","article-title":"Phase III trial: Adjuvant pelvic radiation therapy versus vaginal brachytherapy plus paclitaxel\/carboplatin in high-intermediate and high-risk early stage endometrial cancer","volume":"37","author":"Randall","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2022.09.002_bib0021","doi-asserted-by":"crossref","first-page":"61","DOI":"10.5114\/jcb.2020.92698","article-title":"The role of vaginal brachytherapy in stage I endometrial serous cancer: A systematic review","volume":"12","author":"Lancellotta","year":"2020","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.prro.2022.09.002_bib0022","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ygyno.2007.07.070","article-title":"A gynecologic oncology group randomized phase III trial of whole abdominal irradiation (WAI) vs. cisplatin-ifosfamide and mesna (CIM) as post-surgical therapy in stage I-IV carcinosarcoma (CS) of the uterus","volume":"107","author":"Wolfson","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.prro.2022.09.002_bib0023","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1056\/NEJMoa1813181","article-title":"Adjuvant chemotherapy plus radiation for locally advanced endometrial cancer","volume":"380","author":"Matei","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.prro.2022.09.002_bib0024","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/sj.bjc.6603279","article-title":"Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: Results of a randomised trial","volume":"95","author":"Maggi","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1016\/j.prro.2022.09.002_bib0025","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ygyno.2006.02.007","article-title":"Final analysis of RTOG 9708: Adjuvant postoperative irradiation combined with cisplatin\/paclitaxel chemotherapy following surgery for patients with high-risk endometrial cancer","volume":"103","author":"Greven","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.prro.2022.09.002_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijrobp.2012.02.044","article-title":"A phase II study of intensity modulated radiation therapy to the pelvis for postoperative patients with endometrial carcinoma: Radiation therapy oncology group trial 0418","volume":"84","author":"Jhingran","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2022.09.002_bib0038","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1200\/JCO.2017.77.4273","article-title":"Patient-reported toxicity during pelvic intensity-modulated radiation therapy: NRG Oncology-RTOG 1203","volume":"36","author":"Klopp","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2022.09.002_bib0039","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1080\/0284186X.2021.1926537","article-title":"Outcome and safety analysis of endometrial cancer patients treated with postoperative 3D-conformal radiotherapy or intensity modulated radiotherapy","volume":"60","author":"Onal","year":"2021","journal-title":"Acta Oncol"},{"key":"10.1016\/j.prro.2022.09.002_bib0040","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ijrobp.2013.01.017","article-title":"Hematologic toxicity in RTOG 0418: A phase 2 study of postoperative IMRT for gynecologic cancer","volume":"86","author":"Klopp","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2022.09.002_bib0041","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1200\/JCO.19.02381","article-title":"Improvement in patient-reported outcomes with intensity-modulated radiotherapy (RT) compared with standard RT: A report from the NRG Oncology RTOG 1203 study","volume":"38","author":"Yeung","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2022.09.002_bib0006","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1200\/JCO.19.00151","article-title":"Hysterectomy-corrected uterine corpus cancer incidence trends and differences in relative survival reveal racial disparities and rising rates of nonendometrioid cancers","volume":"37","author":"Clarke","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2022.09.002_bib0007","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.ygyno.2013.05.020","article-title":"Disparities in uterine cancer epidemiology, treatment, and survival among African Americans in the United States","volume":"130","author":"Long","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.prro.2022.09.002_bib0008","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/107327480901600108","article-title":"Race disparities between black and white women in the incidence, treatment, and prognosis of endometrial cancer","volume":"16","author":"Allard","year":"2009","journal-title":"Cancer Control"},{"key":"10.1016\/j.prro.2022.09.002_bib0026","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/bjc.2014.322","article-title":"Treatment preferences and involvement in treatment decision making of patients with endometrial cancer and clinicians","volume":"111","author":"Kunneman","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1016\/j.prro.2022.09.002_bib0027","first-page":"419","article-title":"Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: Clinical and histopathologic study of 540 patients","volume":"56","author":"Aalders","year":"1980","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.prro.2022.09.002_bib0028","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1200\/JCO.2008.20.2424","article-title":"Quality of life after pelvic radiotherapy or vaginal brachytherapy for endometrial cancer: First results of the randomized PORTEC-2 trial","volume":"27","author":"Nout","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2022.09.002_bib0029","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1002\/(SICI)1097-0142(19991115)86:10<2090::AID-CNCR29>3.0.CO;2-7","article-title":"The grading of lymphovascular space invasion in endometrial carcinoma","volume":"86","author":"Hachisuga","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.prro.2022.09.002_bib0030","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.ygyno.2022.01.007","article-title":"Prognostic relevance of the molecular classification in high-grade endometrial cancer for patients staged by lymphadenectomy and without adjuvant treatment","volume":"164","author":"Leon-Castillo","year":"2022","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.prro.2022.09.002_bib0031","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/PGP.0000000000000806","article-title":"Defining substantial lymphovascular space invasion in endometrial cancer","volume":"41","author":"Peters","year":"2021","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.prro.2022.09.002_bib0032","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.ijrobp.2011.04.014","article-title":"External pelvic and vaginal irradiation versus vaginal irradiation alone as postoperative therapy in medium-risk endometrial carcinoma\u2014a prospective randomized study","volume":"82","author":"Sorbe","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2022.09.002_bib0033","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1097\/IGC.0b013e3182643ba0","article-title":"External pelvic and vaginal irradiation versus vaginal irradiation alone as postoperative therapy in medium-risk endometrial carcinoma: A prospective, randomized study\u2014quality-of-life analysis","volume":"22","author":"Sorbe","year":"2012","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.prro.2022.09.002_bib0034","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1136\/ijgc-2020-001199","article-title":"External beam radiotherapy versus vaginal brachytherapy in patients with stage II endometrial cancer: A systematic review and meta-analysis","volume":"30","author":"Narasimhulu","year":"2020","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.prro.2022.09.002_bib0035","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.ijrobp.2018.04.049","article-title":"Multi-institutional analysis of vaginal brachytherapy alone for women with stage II endometrial carcinoma","volume":"101","author":"Harkenrider","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2022.09.002_bib0036","first-page":"437","volume":"14","author":"Hogberg","year":"2004","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.prro.2022.09.002_bib0042","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/S0360-3016(00)00771-9","article-title":"Intensity-modulated whole pelvic radiation therapy in patients with gynecologic malignancies","volume":"48","author":"Roeske","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2022.09.002_bib0043","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/S0360-3016(01)02785-7","article-title":"Intensity-modulated whole pelvic radiotherapy in women with gynecologic malignancies","volume":"52","author":"Mundt","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2022.09.002_bib0044","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/j.ijrobp.2008.04.046","article-title":"Dosimetric comparison of bone marrow-sparing intensity-modulated radiotherapy versus conventional techniques for treatment of cervical cancer","volume":"71","author":"Mell","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2022.09.002_bib0045","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.ijrobp.2004.12.029","article-title":"Intensity-modulated radiation therapy after hysterectomy: Comparison with conventional treatment and sensitivity of the normal-tissue-sparing effect to margin size","volume":"62","author":"Ahamad","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2022.09.002_bib0046","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3109\/02841860903410372","article-title":"Dosimetric comparison of postoperative whole pelvic radiotherapy for endometrial cancer using three-dimensional conformal radiotherapy, intensity-modulated radiotherapy, and helical tomotherapy","volume":"49","author":"Yang","year":"2010","journal-title":"Acta Oncol"},{"key":"10.1016\/j.prro.2022.09.002_bib0047","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ygyno.2016.07.116","article-title":"Impact of postoperative intensity-modulated radiation therapy (IMRT) on the rate of bowel obstruction in gynecologic malignancy","volume":"143","author":"Shih","year":"2016","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.prro.2022.09.002_bib0048","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.ijrobp.2013.06.2059","article-title":"Early clinical outcomes and toxicity of intensity modulated versus conventional pelvic radiation therapy for locally advanced cervix carcinoma: A prospective randomized study","volume":"87","author":"Gandhi","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2022.09.002_bib0049","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.ijrobp.2010.04.041","article-title":"Clinical outcomes of intensity-modulated pelvic radiation therapy for carcinoma of the cervix","volume":"80","author":"Hasselle","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2022.09.002_bib0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijrobp.2012.01.023","article-title":"Pelvic normal tissue contouring guidelines for radiation therapy: A Radiation Therapy Oncology Group consensus panel atlas","volume":"83","author":"Gay","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2022.09.002_bib0051","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ijrobp.2020.08.061","article-title":"NRG Oncology\/RTOG consensus guidelines for delineation of clinical target volume for intensity modulated pelvic radiation therapy in postoperative treatment of endometrial and cervical cancer: An update","volume":"109","author":"Small","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2022.09.002_bib0052","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ijrobp.2010.08.024","article-title":"Vaginal motion and bladder and rectal volumes during pelvic intensity-modulated radiation therapy after hysterectomy","volume":"82","author":"Jhingran","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2022.09.002_bib0053","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S1470-2045(18)30079-2","article-title":"Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): Final results of an international, open-label, multicentre, randomised, phase 3 trial","volume":"19","author":"de Boer","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.prro.2022.09.002_bib0054","unstructured":"Cancer Trials Support Unit. A randomized phase III study of standard vs. IMRT pelvic radiation for post-operative treatment of endometrial and cervical cancer (TIME-C) RTOG 1203 study protocol. Available at: https:\/\/www.ctsu.org\/readfile.aspx?sectionid=30467. Accessed January 25, 2022."},{"key":"10.1016\/j.prro.2022.09.002_bib0063","first-page":"833","article-title":"Adjuvant chemoradiotherapy vs. radiotherapy alone in early-stage high-risk endometrial cancer: A systematic review and meta-analysis","volume":"23","author":"Jingjing","year":"2019","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.prro.2022.09.002_bib0064","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1200\/JCO.2004.00.7617","article-title":"Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: A Gynecologic Oncology Group Study","volume":"24","author":"Randall","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2022.09.002_bib0086","first-page":"206","article-title":"Sentinel lymph node mapping with staging lymphadenectomy for patients with endometrial cancer increases the detection of metastasis","volume":"141","author":"Holloway","year":"2016","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.prro.2022.09.002_bib0087","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ygyno.2019.11.002","article-title":"Multicenter study comparing oncologic outcomes after lymph node assessment via a sentinel lymph node algorithm versus comprehensive pelvic and paraaortic lymphadenectomy in patients with serous and clear cell endometrial carcinoma","volume":"156","author":"Schlappe","year":"2020","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.prro.2022.09.002_bib0088","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ygyno.2014.09.011","article-title":"Sentinel node biopsy for the management of early stage endometrial cancer: Long-term results of the SENTI-ENDO study","volume":"136","author":"Darai","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.prro.2022.09.002_bib0089","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S1470-2045(17)30068-2","article-title":"A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): A multicentre, prospective, cohort study","volume":"18","author":"Rossi","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.prro.2022.09.002_bib0090","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1001\/jamasurg.2020.5060","article-title":"Assessment of sentinel lymph node biopsy vs lymphadenectomy for intermediate- and high-grade endometrial cancer staging","volume":"156","author":"Cusimano","year":"2021","journal-title":"JAMA Surg"},{"key":"10.1016\/j.prro.2022.09.002_bib0091","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1245\/s10434-008-9841-1","article-title":"Use of the sentinel node procedure to stage endometrial cancer","volume":"15","author":"Ballester","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.prro.2022.09.002_bib0092","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1136\/ijgc-2019-000934","article-title":"Retrospective detection of isolated tumor cells by immunohistochemistry in sentinel lymph node biopsy performed for endometrial carcinoma: Is there clinical significance?","volume":"30","author":"Goebel","year":"2020","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.prro.2022.09.002_bib0093","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.ygyno.2019.07.018","article-title":"Lymph node micrometastases and outcome of endometrial cancer","volume":"154","author":"Ignatov","year":"2019","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.prro.2022.09.002_bib0094","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1097\/IGC.0000000000001047","article-title":"The utility of sentinel lymph node mapping in high-grade endometrial cancer","volume":"27","author":"Tanner","year":"2017","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.prro.2022.09.002_bib0095","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ygyno.2017.05.024","article-title":"Isolated tumor cells identified by sentinel lymph node mapping in endometrial cancer: Does adjuvant treatment matter?","volume":"146","author":"Plante","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.prro.2022.09.002_bib0096","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1245\/s10434-015-5040-z","article-title":"Low-volume lymph node metastasis discovered during sentinel lymph node mapping for endometrial carcinoma","volume":"23","author":"St Clair","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.prro.2022.09.002_bib0097","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/cncr.31901","article-title":"Mismatch repair deficiency identifies patients with high-intermediate-risk (HIR) endometrioid endometrial cancer at the highest risk of recurrence: A prognostic biomarker","volume":"125","author":"Backes","year":"2019","journal-title":"Cancer"},{"key":"10.1016\/j.prro.2022.09.002_bib0114","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1200\/JCO.20.00549","article-title":"Molecular classification of the PORTEC-3 trial for high-risk endometrial cancer: Impact on prognosis and benefit from adjuvant therapy","volume":"38","author":"Leon-Castillo","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2022.09.002_bib0115","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1158\/1078-0432.CCR-15-2878","article-title":"Improved risk assessment by integrating molecular and clinicopathological factors in early-stage endometrial cancer-combined analysis of the PORTEC cohorts","volume":"22","author":"Stelloo","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.prro.2022.09.002_bib0055","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.brachy.2015.09.012","article-title":"Vaginal brachytherapy for postoperative endometrial cancer: 2014 Survey of the American Brachytherapy Society","volume":"15","author":"Harkenrider","year":"2016","journal-title":"Brachytherapy."},{"key":"10.1016\/j.prro.2022.09.002_bib0056","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.brachy.2016.04.005","article-title":"American Brachytherapy Task Group report: Adjuvant vaginal brachytherapy for early-stage endometrial cancer: A comprehensive review","volume":"16","author":"Harkenrider","year":"2017","journal-title":"Brachytherapy."},{"key":"10.1016\/j.prro.2022.09.002_bib0057","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.brachy.2011.08.005","article-title":"American Brachytherapy Society consensus guidelines for adjuvant vaginal cuff brachytherapy after hysterectomy","volume":"11","author":"Small","year":"2012","journal-title":"Brachytherapy."},{"key":"10.1016\/j.prro.2022.09.002_bib0058","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1136\/ijgc-2020-001623","article-title":"Low-dose adjuvant vaginal cylinder brachytherapy for early-stage non-endometrioid endometrial cancer: Recurrence risk and survival outcomes","volume":"30","author":"Smart","year":"2020","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.prro.2022.09.002_bib0059","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.brachy.2019.02.008","article-title":"Compendium of fractionation choices for gynecologic HDR brachytherapy-An American Brachytherapy Society task group report","volume":"18","author":"Albuquerque","year":"2019","journal-title":"Brachytherapy."},{"key":"10.1016\/j.prro.2022.09.002_bib0060","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.ijrobp.2010.10.071","article-title":"Determination of prognostic factors for vaginal mucosal toxicity associated with intravaginal high-dose rate brachytherapy in patients with endometrial cancer","volume":"82","author":"Bahng","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2022.09.002_bib0061","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.semradonc.2020.05.008","article-title":"Evidence-based dose planning aims and dose prescription in image-guided brachytherapy combined with radiochemotherapy in locally advanced cervical cancer","volume":"30","author":"Tanderup","year":"2020","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.prro.2022.09.002_bib0062","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.brachy.2011.12.009","article-title":"Is there any advantage to three-dimensional planning for vaginal cuff brachytherapy?","volume":"11","author":"Kim","year":"2012","journal-title":"Brachytherapy"},{"issue":"6","key":"10.1016\/j.prro.2022.09.002_bib0065","article-title":"Adjuvant progestagens for endometrial cancer","author":"Martin-Hirsch","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.prro.2022.09.002_bib0066","series-title":"SEER Survival Monograph: Cancer Survival Among Adults: US SEER Program, 1988-2001, Patient and Tumor Characteristics","year":"2007"},{"key":"10.1016\/j.prro.2022.09.002_bib0067","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1016\/j.ejca.2010.06.002","article-title":"Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer\u2014results from two randomised studies","volume":"1","author":"Hogberg","year":"2010","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.prro.2022.09.002_bib0068","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ygyno.2016.02.002","article-title":"Treatment related outcomes in high-risk endometrial carcinoma: Canadian high risk endometrial cancer consortium (CHREC)","volume":"141","author":"Bernardini","year":"2016","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.prro.2022.09.002_bib0069","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1136\/ijgc-2018-000030","article-title":"Impact of adjuvant treatment on outcome in high-risk early-stage endometrial cancer: A retrospective three-center study","volume":"29","author":"Helpman","year":"2019","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.prro.2022.09.002_bib0070","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ygyno.2018.03.002","article-title":"The role of adjuvant therapy in stage IA serous and clear cell uterine cancer: A multi-institutional pooled analysis","volume":"149","author":"Qu","year":"2018","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.prro.2022.09.002_bib0071","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.brachy.2018.08.015","article-title":"Comparison of outcomes in early-stage uterine clear cell carcinoma and serous carcinoma","volume":"18","author":"Zhang","year":"2019","journal-title":"Brachytherapy"},{"key":"10.1016\/j.prro.2022.09.002_bib0072","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/path.4947","article-title":"The genetic landscape of endometrial clear cell carcinomas","volume":"243","author":"DeLair","year":"2017","journal-title":"J Pathol"},{"key":"10.1016\/j.prro.2022.09.002_bib0073","first-page":"e10283","article-title":"Carcinosarcoma of the uterus: A study from the Surveillance Epidemiology and End Result (SEER) database","volume":"12","author":"Nama","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.prro.2022.09.002_bib0074","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ygyno.2007.09.029","article-title":"Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: A Japanese Gynecologic Oncology Group study","volume":"1","author":"Susumu","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.prro.2022.09.002_bib0075","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.ijrobp.2021.02.055","article-title":"A multi-institutional analysis of adjuvant chemotherapy and radiation sequence in women with stage IIIC endometrial cancer","volume":"110","author":"Hathout","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2022.09.002_bib0076","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1006\/gyno.2002.6789","article-title":"Stage IIIC endometrioid corpus cancer includes distinct subgroups","volume":"87","author":"Mariani","year":"2002","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.prro.2022.09.002_bib0077","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S0090-8258(03)00052-0","article-title":"Endometrial cancer: Predictors of peritoneal failure","volume":"89","author":"Mariani","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.prro.2022.09.002_bib0078","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1006\/gyno.2002.6713","article-title":"Assessment of prognostic factors in stage IIIA endometrial cancer","volume":"86","author":"Mariani","year":"2002","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.prro.2022.09.002_bib0079","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3802\/jgo.2015.26.4.284","article-title":"Adjuvant sequential chemo and radiotherapy improves the oncological outcome in high risk endometrial cancer","volume":"26","author":"Signorelli","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.prro.2022.09.002_bib0080","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ygyno.2010.12.338","article-title":"A phase II trial of carboplatin and docetaxel followed by radiotherapy given in a \"sandwich\" method for stage III, IV, and recurrent endometrial cancer","volume":"121","author":"Geller","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.prro.2022.09.002_bib0081","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ygyno.2009.03.027","article-title":"Adjuvant carboplatin and paclitaxel chemotherapy interposed with involved field radiation for advanced endometrial cancer","volume":"114","author":"Lupe","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.prro.2022.09.002_bib0082","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.ygyno.2009.06.005","article-title":"A multicenter evaluation of sequential multimodality therapy and clinical outcome for the treatment of advanced endometrial cancer","volume":"114","author":"Secord","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.prro.2022.09.002_bib0083","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ijrobp.2006.08.006","article-title":"Adjuvant paclitaxel and carboplatin chemotherapy with involved field radiation in advanced endometrial cancer: A sequential approach","volume":"67","author":"Lupe","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2022.09.002_bib0085","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.brachy.2018.08.005","article-title":"Does adjuvant concurrent or sequential chemotherapy increase the radiation-related toxicity of vaginal brachytherapy for endometrial cancer patients?","volume":"17","author":"Nieto","year":"2018","journal-title":"Brachytherapy"},{"key":"10.1016\/j.prro.2022.09.002_bib0098","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1136\/ijgc-2020-001924","article-title":"Reduced lymphedema after sentinel lymph node biopsy versus lymphadenectomy for endometrial cancer","volume":"31","author":"Glaser","year":"2021","journal-title":"Int J Gynecol Cancer"},{"issue":"2 Pt 1","key":"10.1016\/j.prro.2022.09.002_bib0099","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/AOG.0000000000000372","article-title":"Lymphedema after surgery for endometrial cancer: Prevalence, risk factors, and quality of life","volume":"124","author":"Yost","year":"2014","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.prro.2022.09.002_bib0100","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1093\/jnci\/djn397","article-title":"Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: Randomized clinical trial","volume":"100","author":"Benedetti Panici","year":"2008","journal-title":"J Natl Cancer Inst"},{"issue":"9","key":"10.1016\/j.prro.2022.09.002_bib0101","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007585.pub3","article-title":"Lymphadenectomy for the management of endometrial cancer","author":"Frost","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.prro.2022.09.002_bib0102","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007585.pub2","article-title":"Lymphadenectomy for the management of endometrial cancer","author":"May","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.prro.2022.09.002_bib0103","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0140-6736(08)61766-3","article-title":"Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): A randomised study","volume":"373","author":"study group","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.prro.2022.09.002_bib0104","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1245\/s10434-016-5731-0","article-title":"Call for surgical nodal staging in women with ESMO\/ESGO\/ESTRO high-intermediate risk endometrial cancer: A multicentre cohort analysis from the FRANCOGYN study group","volume":"24","author":"Ouldamer","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.prro.2022.09.002_bib0105","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1002\/jso.26265","article-title":"Surgical lymph node assessment influences adjuvant therapy in clinically apparent stage I endometrioid endometrial carcinoma, meeting Mayo criteria for lymphadenectomy","volume":"123","author":"Pendlebury","year":"2021","journal-title":"J Surg Oncol"},{"issue":"8 Suppl","key":"10.1016\/j.prro.2022.09.002_bib0106","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1002\/1097-0142(19901015)60:8+<2035::AID-CNCR2820601515>3.0.CO;2-8","article-title":"Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group study","volume":"60","author":"Creasman","year":"1987","journal-title":"Cancer"},{"key":"10.1016\/j.prro.2022.09.002_bib0107","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.ygyno.2020.03.025","article-title":"Incidence of pelvic lymph node metastasis using modern FIGO staging and sentinel lymph node mapping with ultrastaging in surgically staged patients with endometrioid and serous endometrial carcinoma","volume":"157","author":"Mueller","year":"2020","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.prro.2022.09.002_bib0108","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ygyno.2020.02.014","article-title":"A modern assessment of the surgical pathologic spread and nodal dissemination of endometrial cancer","volume":"157","author":"Praiss","year":"2020","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.prro.2022.09.002_bib0109","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ygyno.2018.02.021","article-title":"Lymphnode staging update in the American Joint Committee on Cancer 8th Edition cancer staging manual","volume":"150","author":"Olawaiye","year":"2018","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.prro.2022.09.002_bib0110","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.humpath.2016.10.023","article-title":"Microcystic, elongated, and fragmented pattern invasion is mainly associated with isolated tumor cell pattern metastases in International Federation of Gynecology and Obstetrics grade I endometrioid endometrial cancer","volume":"62","author":"Pelletier","year":"2017","journal-title":"Hum Pathol"},{"key":"10.1016\/j.prro.2022.09.002_bib0111","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.ygyno.2008.11.014","article-title":"A randomized phase III trial in advanced endometrial carcinoma of surgery and volume directed radiation followed by cisplatin and doxorubicin with or without paclitaxel: A Gynecologic Oncology Group study","volume":"112","author":"Homesley","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.prro.2022.09.002_bib0112","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ygyno.2019.03.240","volume":"154","author":"Spirtos","year":"2019","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.prro.2022.09.002_bib0113","doi-asserted-by":"crossref","first-page":"879","DOI":"10.2967\/jnumed.115.170597","article-title":"High diagnostic value of 18F-FDG PET\/CT in endometrial cancer: Systematic review and meta-analysis of the literature","volume":"57","author":"Bollineni","year":"2016","journal-title":"J Nucl Med"},{"key":"10.1016\/j.prro.2022.09.002_bib0116","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/path.5373","article-title":"Clinicopathological and molecular characterisation of 'multiple-classifier' endometrial carcinomas","volume":"250","author":"Leon-Castillo","year":"2020","journal-title":"J Pathol"},{"key":"10.1016\/j.prro.2022.09.002_bib0117","doi-asserted-by":"crossref","first-page":"3928","DOI":"10.1158\/1078-0432.CCR-20-0953","article-title":"Randomized phase II trial of carboplatin-paclitaxel compared with carboplatin-paclitaxel-trastuzumab in advanced (stage III-IV) or recurrent uterine serous carcinomas that overexpress Her2\/Neu (NCT01367002): Updated overall survival analysis","volume":"26","author":"Fader","year":"2020","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.prro.2022.09.002_bib0118","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.ygyno.2021.07.007","article-title":"Clear cell endometrial carcinomas with mismatch repair deficiency have a favorable prognosis: A systematic review and meta-analysis","volume":"162","author":"Travaglino","year":"2021","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.prro.2022.09.002_bib0119","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ygyno.2020.04.043","article-title":"Molecular subtypes of clear cell carcinoma of the endometrium: Opportunities for prognostic and predictive stratification","volume":"158","author":"Kim","year":"2020","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.prro.2022.09.002_bib0120","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/ijgo.13937","article-title":"Prognostic value of the TCGA molecular classification in uterine carcinosarcoma","volume":"158","author":"Travaglino","year":"2021","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.prro.2022.09.002_bib0121","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.jclinepi.2009.06.005","article-title":"Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement","volume":"62","author":"Moher","year":"2009","journal-title":"J Clin Epidemiol"}],"container-title":["Practical Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850022002739?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850022002739?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T10:25:01Z","timestamp":1761819901000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879850022002739"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":120,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S1879850022002739"],"URL":"https:\/\/doi.org\/10.1016\/j.prro.2022.09.002","relation":{},"ISSN":["1879-8500"],"issn-type":[{"value":"1879-8500","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiation Therapy for Endometrial Cancer: An American Society for Radiation Oncology Clinical Practice Guideline","name":"articletitle","label":"Article Title"},{"value":"Practical Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prro.2022.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American Society for Radiation Oncology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}